An Electrospray Sequential Mass Spectrometry Fragmentation Scheme of Erythromycin A and Its Application for the Elucidation of the Structures of Its Natural Co-Metabolites.

Abstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Candy JiangSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK.ORCID 0000-0002-8469-1122

Paul J GatesSchool of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, UK.ORCID 0000-0001-8619-7745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products such as polyketides are a fertile target for drug discovery. Methodologies relating to discovery, metabolism, synthesis and biosynthesis of polyketides have evolved considerably since they were first studied in the early 20th century. The antibiotic erythromycin, produced by the

Indexed as

Biological ProductsErythromycinSpectrometry, Mass, Electrospray IonizationAnti-Bacterial AgentsMacrolidesMolecular StructureStreptomycesAnti-Bacterial AgentsBiological ProductsErythromycinMacrolideserythromycinfragmentation schememacrolidenew erythromycinpolyketide antibioticssequential mass spectrometrystructural elucidation

Identifiers

PMID41900032

DOI10.3390/molecules31060928

PMCPMC13028665

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.